Relaxant effects of the potassium channel activators BRL 38227 and pinacidil on guinea-pig and human airway smooth muscle, and blockade of their effects by glibenclamide and BRL 31660. 1993

D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
SmithKline Beecham Pharmaceuticals, Great Burgh, Epsom, Surrey, UK.

The airways relaxant effects and mechanism of action of the potassium channel activators BRL 38227 and pinacidil have been compared in guinea-pig and human airways. BRL 38227 was a potent relaxant in guinea-pig isolated trachealis (IC50 = 4.9 x 10(-7) M against spontaneous tone) and human isolated bronchi (IC50 = 4.75 x 10(-7) M against histamine-induced tone) and was eight- and six-fold more potent respectively than pinacidil. The relaxant effects of both compounds were shown to be markedly attenuated by glibenclamide (10(-5) M) and BRL 31660 (10(-5) M), with the nature of the blockade being species/tissue dependent. Glibenclamide (20 mg/kg iv) also inhibited the protective effects of BRL 38227 (50 micrograms/kg iv) and pinacidil (500 micrograms/kg iv) on histamine-induced changes in airways resistance and dynamic compliance in the anaesthetized guinea-pig, although the effects were short-lived. That both BRL 38227 and pinacidil owed their relaxant effects to potassium channel activation was supported by their ability to stimulate 42/43K efflux from guinea-pig trachealis preloaded with the radiotracer at concentrations of 10(-7) - 10(-5) M and 10(-5) M respectively. Pretreatment with either glibenclamide (10(-5) M) or BRL 31660 (10(-5) M) ablated the response to both compounds. These studies show that two mechanistically distinct potassium channel blockers, glibenclamide and BRL 31660, do not substantially differentiate between the actions of BRL 38227 and pinacidil, although differences do occur, particularly at high concentrations in vitro.

UI MeSH Term Description Entries
D008297 Male Males
D009126 Muscle Relaxation That phase of a muscle twitch during which a muscle returns to a resting position. Muscle Relaxations,Relaxation, Muscle,Relaxations, Muscle
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D011197 Potassium Radioisotopes Unstable isotopes of potassium that decay or disintegrate emitting radiation. K atoms with atomic weights 37, 38, 40, and 42-45 are radioactive potassium isotopes. Radioisotopes, Potassium
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D012137 Respiratory System The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about. Respiratory Tract,Respiratory Systems,Respiratory Tracts,System, Respiratory,Tract, Respiratory
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D005260 Female Females

Related Publications

D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
December 1990, The American review of respiratory disease,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
April 1992, European journal of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
May 1990, European journal of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
November 1988, European journal of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
October 1992, Naunyn-Schmiedeberg's archives of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
February 1992, British journal of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
September 1993, British journal of pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
January 1992, Biochemical pharmacology,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
January 1987, Lung,
D R Buckle, and J R Arch, and N E Bowring, and K A Foster, and J F Taylor, and S G Taylor, and D J Shaw
March 1992, British journal of pharmacology,
Copied contents to your clipboard!